IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases.
Industry: Health Care
Latest Trade: $8.22 0.00 (0.0%)
First Day Return: -1.5%
Return from IPO: -99.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/19/2021 |
Offer Price | $16.75 |
Price Range $15.00 - $18.00 | |
Offer Shares (mm) | 1.2 |
Deal Size ($mm) | $20 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/09/2021 |
Offer Price | $16.75 |
Price Range $15.00 - $18.00 | |
Offer Shares (mm) | 1.2 |
Deal Size ($mm) | $20 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
H.C. Wainwright |
Company Data | |
---|---|
Headquarters | Paris, France |
Founded | 2006 |
Employees | 23 |
Website www.biophytis.com |